- 11/04/2022Background The Rwanda National Council for Science and Technology (NCST) supports the Government of Rwanda’s vision to address national priorities…
- 11/04/2022A new, more participatory and balanced system of governance has been introduced for GloPID-R member Institut Pasteur International Network and…
- 02/10/2021When manufacturers are developing new vaccines, they assess their efficacy mostly in healthy adults. However, people with a compromised immune system are at greater risk of complications from…
- 02/10/2021The Covid-19 Therapeutics Accelerator – which is co-funded and co-hosted by donors including Wellcome – has awarded £8 million to…
- 02/10/2021Second call for proposals In April 2021, FAPESP launched a second COVID-19 call for proposals, targeted to the scientific community…
- 02/10/2021On September 16, 2021 the European Commission launched the European Health Emergency Preparedness and Response Authority (HERA) to prevent, detect and…
- 02/10/2021An EU-wide network of COVID-19 therapeutic adaptive platform trials was set up early in the summer of 2020. The first…
- 02/10/2021CIHR, with support from the Government of Canada, continues to respond to emerging COVID-19 research priorities, and recent funding efforts…
- 02/10/2021By Dr Frederik Kristensen, Deputy CEO, CEPI Over the course of 2021, the world has witnessed and dramatically benefitted from…
- 02/10/2021The Coalition for Epidemic Preparedness Innovations (CEPI), a GloPID-R observer, has announced the appointment of health experts Dr Nísia Trindade…
